The effects of octreotide in dilated cardiomyopathy - An open-label trial in 12 patients


Creative Commons License

Eryol N. K. , Guven M., Topsakal R., Sungur M., Ozdogru I., Inanc T., ...More

JAPANESE HEART JOURNAL, vol.45, no.4, pp.613-621, 2004 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 45 Issue: 4
  • Publication Date: 2004
  • Doi Number: 10.1536/jhj.45.613
  • Journal Name: JAPANESE HEART JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.613-621
  • Keywords: dilated cardiomyopathy, octreotide, CONGESTIVE-HEART-FAILURE, IGF-I AXIS, GROWTH-HORMONE, SOMATOSTATIN ANALOG, EXERCISE CAPACITY, GUINEA-PIG, IMPROVEMENT, HYPERTROPHY, MECHANISMS, THERAPY
  • Erciyes University Affiliated: Yes

Abstract

Octreotide, a somatostatin analogue, has been found effective in the treatment of acromegalic cardiomyopathy. We investigated whether intermittent octreotide therapy had beneficial effects in patients with ischemic or idiopathic dilated cardiomyopathy, which are refractory to conventional therapy.